IL1A and chronic myelogenous leukemia, BCR-ABL1 positive: In CAo + CAt treatment, CML in well-controlled blood glucose subgroup had the lowest increase and IL-1α increased less in well-controlled compared to the partially controlled and decreased in poor-controlled blood glucose.